Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0256 | 0.4532 | 0.4532 |
Loa Loa (eye worm) | hypothetical protein | 0.0215 | 0.2661 | 0.2661 |
Loa Loa (eye worm) | hypothetical protein | 0.016 | 0.0141 | 0.0141 |
Loa Loa (eye worm) | hypothetical protein | 0.0256 | 0.4532 | 0.4532 |
Treponema pallidum | sodium- and chloride- dependent transporter | 0.0256 | 0.4532 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.016 | 0.0141 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.016 | 0.0141 | 0.0141 |
Loa Loa (eye worm) | hypothetical protein | 0.0215 | 0.2661 | 0.2661 |
Onchocerca volvulus | 0.0375 | 1 | 1 | |
Onchocerca volvulus | 0.0375 | 1 | 1 | |
Brugia malayi | LBP / BPI / CETP family, N-terminal domain containing protein | 0.0375 | 1 | 1 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0337 | 0.8242 | 0.5 |
Onchocerca volvulus | 0.0256 | 0.4532 | 0.4454 | |
Echinococcus multilocularis | serotonin transporter | 0.0256 | 0.4532 | 1 |
Onchocerca volvulus | 0.0375 | 1 | 1 | |
Loa Loa (eye worm) | LBP/BPI/CETP family domain-containing protein | 0.0375 | 1 | 1 |
Loa Loa (eye worm) | solute carrier family 6 member 4 | 0.0256 | 0.4532 | 0.4532 |
Mycobacterium tuberculosis | Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) | 0.0313 | 0.7155 | 0.5 |
Onchocerca volvulus | 0.0215 | 0.2661 | 0.2556 | |
Loa Loa (eye worm) | serotonin transporter b | 0.0256 | 0.4532 | 0.4532 |
Brugia malayi | hypothetical protein | 0.0215 | 0.2661 | 0.2556 |
Echinococcus granulosus | serotonin transporter | 0.0256 | 0.4532 | 1 |
Onchocerca volvulus | 0.0375 | 1 | 1 | |
Brugia malayi | LBP / BPI / CETP family, C-terminal domain containing protein | 0.0215 | 0.2661 | 0.2556 |
Loa Loa (eye worm) | LBP/BPI/CETP family domain-containing protein | 0.0215 | 0.2661 | 0.2661 |
Brugia malayi | LBP / BPI / CETP family, C-terminal domain containing protein | 0.0215 | 0.2661 | 0.2556 |
Loa Loa (eye worm) | hypothetical protein | 0.0215 | 0.2661 | 0.2661 |
Onchocerca volvulus | 0.0375 | 1 | 1 | |
Brugia malayi | LBP / BPI / CETP family, C-terminal domain containing protein | 0.0375 | 1 | 1 |
Onchocerca volvulus | 0.0375 | 1 | 1 | |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0256 | 0.4532 | 0.4454 |
Onchocerca volvulus | 0.0215 | 0.2661 | 0.2556 | |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.0256 | 0.4532 | 1 |
Onchocerca volvulus | 0.0375 | 1 | 1 | |
Loa Loa (eye worm) | LBP/BPI/CETP family domain-containing protein | 0.0215 | 0.2661 | 0.2661 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.0256 | 0.4532 | 1 |
Brugia malayi | hypothetical protein | 0.0215 | 0.2661 | 0.2556 |
Loa Loa (eye worm) | hypothetical protein | 0.0215 | 0.2661 | 0.2661 |
Loa Loa (eye worm) | hypothetical protein | 0.016 | 0.0141 | 0.0141 |
Loa Loa (eye worm) | hypothetical protein | 0.0375 | 1 | 1 |
Loa Loa (eye worm) | norepinephrine transporter | 0.0256 | 0.4532 | 0.4532 |
Loa Loa (eye worm) | hypothetical protein | 0.016 | 0.0141 | 0.0141 |
Brugia malayi | LBP / BPI / CETP family, C-terminal domain containing protein | 0.0215 | 0.2661 | 0.2556 |
Loa Loa (eye worm) | hypothetical protein | 0.0256 | 0.4532 | 0.4532 |
Loa Loa (eye worm) | hypothetical protein | 0.0215 | 0.2661 | 0.2661 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0337 | 0.8242 | 0.5 |
Onchocerca volvulus | 0.0375 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MBC>99.9 (functional) | = 1.95 umol/L | Bactericidal activity against Escherichia coli CCM 4517 after 48 hrs by microdilution broth method | ChEMBL. | 25442318 |
MFC (functional) | = 1.95 umol/L | Fungicidal activity against Candida albicans ATCC 44859 after 48 hrs by modified standard CSLI M27-A2 method | ChEMBL. | 25442318 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.